Red cell ferritin and iron overload in heterozygous beta-thalassemia
β Scribed by Dr. Martin B. van der Weyden; Hubert Fong; Lynnette J. Hallam; Christine Harrison
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 447 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Purpose To evaluate the magnetic properties of the spleen in chronically transfused, ironβoverloaded patients with sickle cell disease (SCD) and thalassemia major (TM) and to compare splenic iron burdens to those in the liver, heart, pancreas, and kidneys. ## Materials and Methods
## Abstract ## BACKGROUND Approximately 15,000 new cases of myelodysplastic syndromes (MDS) are expected in the United States each year. ## METHODS The mainstay for the management of myelodysplastic syndromes (MDS) is supportive therapy with red blood cell (RBC) transfusions to improve the patie
## Abstract A natural history study was conducted in 142 Thalassemic (Thal), 199 transfused Sickle Cell Disease (TxβSCD, __n__ = 199), and 64 nonβTxβSCD subjects to describe the frequency of ironβrelated morbidity and mortality. Subjects recruited from 31 centers in the US, Canada or the UK were si
The serum ferritin (SERFER) may be elevated and misleading in the setting of chronic disease (chronic inflammation, liver disease, and neoplasm). The red cell ferritin (RB- CFER) may be more stable in clinical situations that affect the SERFER. We compared the ability of SERFER and RBCFER to assess